首页> 外文期刊>Annals of surgical oncology >Variation in the Types of Providers Participating in Breast Cancer Follow-Up Care: A SEER-Medicare Analysis
【24h】

Variation in the Types of Providers Participating in Breast Cancer Follow-Up Care: A SEER-Medicare Analysis

机译:参与乳腺癌随访的提供者类型的变异:Seer-Medicare分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background. The current guidelines do not delineate the types of providers that should participate in early breast cancer follow-up care (within 3 years after completion of treatment). This study aimed to describe the types of providers participating in early follow-up care of older breast cancer survivors and to identify factors associated with receipt of follow-up care from different types of providers. Methods. Stages 1-3 breast cancer survivors treated from 2000 to 2007 were identified in the Surveillance, Epidemiology and End results Medicare database (n = 44,306). Oncologist (including medical, radiation, and surgical) follow-up and primary care visits were defined using Medicare specialty provider codes and linked American Medical Association (AMA) Masterfile. The types of providers involved in follow-up care were summarized. Stepped regression models identified factors associated with receipt of medical oncology follow-up care and factors associated with receipt of medical oncology care alone versus combination oncology follow-up care. Results. Oncology follow-up care was provided for 80 % of the patients: 80 % with a medical oncologist, 46 % with a surgeon, and 39 % with a radiation oncologist after radiation treatment. The patients with larger tumor size, positive axillary nodes, estrogen receptor (ER)-positive status, and chemotherapy treatment were more likely to have medical oncology follow-up care than older patients with higher Charlson comorbidity scores who were not receiving axillary care. The only factor associated with increased likelihood of follow-up care with a combination of oncology providers was regular primary care visits (>2 visits/year). Conclusions. Substantial variation exists in the types of providers that participate in breast cancer follow-up care. Improved guidance for the types of providers involved and delineation of providers’ responsibilities during follow-up care could lead to improved efficiency and quality of care.
机译:背景。目前的指导方针并不划分应参与早期乳腺癌随访护理的提供者类型(治疗完成后3年)。本研究旨在描述参与较老乳腺癌幸存者的早期后续护理的提供者类型,并确定与来自不同类型提供者的后续行动相关联的因素。方法。在监测,流行病学和最终结果Medicare Database(N = 44,306)中鉴定了2000〜2007年治疗的1-3次乳腺癌幸存者。肿瘤科医生(包括医疗,辐射和外科)的后续和初级保健访问是使用Medicare专业提供商代码和联系美国医学协会(AMA)MasterFile定义的。总结了参与随访护理的提供者类型。阶梯回归模型确定了与接收医疗肿瘤后续护理和因素相关的因素,与收到医疗肿瘤护理与组合肿瘤后续护理。结果。为80%的患者提供了肿瘤学随访:80%,医疗肿瘤科医生,46%,外科医生,辐射治疗后,带有放射肿瘤学家的39%。肿瘤大小,阳性腋窝节点,雌激素受体(ER)阳性状态和化疗治疗的患者比老年患者更容易具有医疗肿瘤后续治疗,而不是未接受腋窝护理的较高患者。与肿瘤提供者组合的随访似乎增加的唯一因素是定期的初级保健访问(> 2访问/年)。结论。存在参与乳腺癌随访护理的提供者类型的大量变化。改进了所涉及的提供者类型和划分供应商在后续行动的职责的指导可能导致效率和护理质量提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号